To evaluate the relationship between FOXP3 mRNA expression and tumor progression, we analyzed FOXP3 levels across clinical stages I–IV in both our experimental MMA cohort and the TCGA validation dataset. This evidence concerns the gene FOXP3 and neoplasm.